Oaktree Acquisition Corp. III Life Sciences (OACC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oaktree Acquisition Corp....

    NASDAQ: OACC · Real-Time Price · USD
    10.45
    0.01 (0.10%)
    At close: Sep 05, 2025, 3:59 PM
    10.45
    0.00%
    After-hours: Sep 05, 2025, 04:10 PM EDT

    Oaktree Acquisition III Life Sciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024
    Period Ending Dec 31, 2024
    Revenue
    		 n/a
    Cost of Revenue
    		 n/a
    Gross Profit
    		 n/a
    Operating Income
    		 -703
    Interest Income
    		 1.59M
    Pretax Income
    		 2.66K
    Net Income
    		 2.66K
    Selling & General & Admin
    		 703.61
    Research & Development
    		 n/a
    Other Expenses
    		 n/a
    Operating Expenses
    		 703.61
    Interest Expense
    		 n/a
    Selling & Marketing Expenses
    		 n/a
    Cost & Expenses
    		 703.61
    Income Tax Expense
    		 n/a
    Shares Outstanding (Basic)
    		 24.58M
    Shares Outstanding (Diluted)
    		 24.58M
    EPS (Basic)
    		 0.05
    EPS (Diluted)
    		 0.05
    EBITDA
    		 n/a
    EBIT
    		 -703
    Depreciation & Amortization
    		 703.61

    Add to Watchlist